NPPES file of Aug 9, 2026

John Ericson Margallo, PHARMD

Oncology Pharmacist · Los Angeles, CA

John Ericson Margallo, PHARMD is an oncology pharmacist with a practice address in Los Angeles, California, and NPI 1770230260, issued on Mar 4, 2022. Check the license (California 76981, as entered in NPPES) with the California board that licenses this profession; the federal record below is the public data PlainDoctor holds for this provider.

Record from CMS NPPES, file of Aug 9, 2026 · method · Verify with CMS →

NPPES recordNPPES file of Aug 9, 2026
1770230260
Name
John Ericson Margallo
Credential
PHARMD
Primary taxonomy
Oncology Pharmacist 1835X0200X
License number
76981 CA
Self-reported in NPPES; status is on the state search
Practice location
757 Westwood Plz # B140, Los Angeles, CA 90095
Phone
(310) 206-3784
Enumerated
Mar 4, 2022
Record last updated
Mar 4, 2022
Entity
Type 1 · individual
Public record from CMS NPPES (open it on the CMS NPI Registry). A record is not a license: verify it with the state board.
Download card Updates feed

Also registered at 757 Westwood Plz # B140

A shared address usually means a shared clinic or building; it does not show who employs whom.

  1. Gemilee Bustamante, PHARMDPharmacist1689323909
  2. Victor Lin, PHARM.D.Pharmacist1982178646

Verify John Ericson Margallo in five checks

  1. 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
  2. 2LicenseActive license and public ordersWhich California board licenses this profession
    Search for license 76981
    Check the board
  3. 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
  4. 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
  5. 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
Find the California license search

PlainDoctor does not match the HHS-OIG exclusion list to individual records: most entries carry no NPI. Search the OIG exclusion list by name.

Is this page about you? You can ask us to correct, restrict or remove it: how.

Oncology Pharmacist providers in California

There are 287 oncology pharmacist records in California. No Medicare prescribing, quality score, industry payment or hospital affiliation is published for this NPI.

Other oncology pharmacist records in California

  1. Aseala Abousaud, PHARMD, BCOP, APHWalnut Creek, CA1396611869
  2. Jayrom Acorda, PHARM.D.Palm Springs, CA1497441240
  3. Antonio Acuna, PHARMDSan Diego, CA1629959408
  4. Leena Agrawal, PHARMDSanta Rosa, CA1174221634
  5. Artemio Alanis, PHARMDFairfield, CA1396513982
  6. Prasannaraddi Alavandi, PHARMDPalo Alto, CA1932035482
  7. Maher Alhaja, PHARMDSan Diego, CA1104515964
  8. Nigina Ali, PHARM.D.Martinez, CA1760022545
  9. Linda AllworthPalo Alto, CA1538035969
  10. Eleonora Amcheslavsky, PHARMDGreenbrae, CA1992115729

Common questions

What is John Ericson Margallo, PHARMD's NPI number?

John Ericson Margallo, PHARMD's National Provider Identifier (NPI) is 1770230260, issued on Mar 4, 2022. An NPI identifies a provider in billing; it is not a license.

Where is John Ericson Margallo, PHARMD located?

The NPPES record lists a practice address at 757 Westwood Plz # B140, Los Angeles, CA, 90095. Phone: (310) 206-3784. Providers update this record themselves, so call before visiting.

How can I verify John Ericson Margallo, PHARMD's license?

NPPES lists California license number 76981, as entered by the provider. Search the California board that licenses this profession; the NPPES record confirms identity only.

Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. An NPI identifies who bills; it is not a license.

Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.